WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

CONTEMPORARY UPDATES ON ORAL MUCOSITIS

Dr. Saraswathi K. Gopal* and Dr. Sindhuja N.

ABSTRACT

Head and neck cancer, principally squamous cell carcinomas, is one of the main oncological problems due to its high mortality rate as well as the after-effects of the treatment. It makes up 4-5% of all cancers.[1] Antineoplastic therapy has been witnessing continuous improvement in terms of overall survival rates and progression free survival; nevertheless, it is still accompanied by a cluster of side effects affecting the quality of life (QoL).[2] Oral mucositis (OM) is one of the most prominent side effects of cancer treatment and is believed to have a significant impact on the quality of life (QoL) of the affected patients.[3] It is characterized by the presence of erythema and edema of the oral and oropharyngeal mucosa culminating in ulcerative erosive lesions 3–5 days or 7–10 days from the initiation of chemotherapy (CT) or radiotherapy (RT) respectively.[4,5] Mucositis represents a clinical continuum: although some patients have mucositis limited to patches of mildly sore erythematous mucosae, in other patients diffuse areas of painful ulceration and pseudo membranes appearance had been evident. The variability in the severity of mucositis is one reason there has been undermined attention of its prevalence in cancer patients and also in its management.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More